No Data
No Data
Exploring AIM ImmunoTech's Earnings Expectations
AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
AIM ImmunoTech Analyst Ratings
Maxim Group Maintains AIM ImmunoTech(AIM.US) With Buy Rating, Cuts Target Price to $1
AIM ImmunoTech Price Target Lowered to $1 From $2 at Maxim
No Data
No Data